1. The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment
   Wei Mu et al, 2022, Pharmaceuticals CrossRef
2. Mitochondrial quality control and its role in osteoporosis
   Chunlu Yan et al, 2023, Frontiers in Endocrinology CrossRef
3. The role of melatonin in the development of postmenopausal osteoporosis
   Keda Yang et al, 2022, Frontiers in Pharmacology CrossRef
4. SIRT3: A Potential Target of Different Types of Osteoporosis
   Binjing Pan et al, 2024, Cell Biochemistry and Biophysics CrossRef
5. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation
   Xiaoman Liu et al, 2022, International Immunopharmacology CrossRef
6. Oxidative stress: A common pathological state in a high-risk population for osteoporosis
   Chi Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. Advances in SIRT3 involvement in regulating autophagy-related mechanisms
   Shuangyun Xi et al, 2024, Cell Division CrossRef
8. A silane-based coupling strategy for enhancing the mechanical properties of proanthocyanidin nanocoatings on Ti dental implants
   Qiyue Zhou et al, 2022, Applied Surface Science CrossRef
9. Metformin Promotes Differentiation and Attenuates H2O2-Induced Oxidative Damage of Osteoblasts via the PI3K/AKT/Nrf2/HO-1 Pathway
   Keda Yang et al, 2022, Frontiers in Pharmacology CrossRef
10. Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis
    Keda Yang et al, 2022, Frontiers in Physiology CrossRef
11. RETRACTED: Trehalose improves palmitic acid‐induced apoptosis of osteoblasts by regulating SIRT3‐medicated autophagy via the AMPK/mTOR/ULK1 pathway
    Lili Cao et al, 2022, The FASEB Journal CrossRef
12. The Function of Metformin in Aging-Related Musculoskeletal Disorders
    Yanhong Song et al, 2022, Frontiers in Pharmacology CrossRef
13. Metformin reverses oxidative stress‑induced mitochondrial dysfunction in pre‑osteoblasts via the EGFR/GSK‑3β/calcium pathway
    Fangming Cao et al, 2023, International Journal of Molecular Medicine CrossRef
14. Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study
    Yaotian Cai et al, 2024, Osteoporosis International CrossRef
15. The Differential Effect of Metformin on Osteocytes, Osteoblasts, and Osteoclasts
    Teun J. de Vries et al, 2023, Current Osteoporosis Reports CrossRef
16. Metformin suppresses Oxidative Stress induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis
    Bohao Chen et al, 2023, Life Sciences CrossRef
17. Targeting ROS-induced osteoblast senescence and RANKL production by Prussian blue nanozyme based gene editing platform to reverse osteoporosis
    Ke Li et al, 2023, Nano Today CrossRef
18. Epigenetic regulations of cellular senescence in osteoporosis
    Shaochuan Huo et al, 2024, Ageing Research Reviews CrossRef
19. Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging
    Tongyu C Wikramanayake et al, 2022, Expert Opinion on Therapeutic Targets CrossRef
20. Role of SIRT3 in bone homeostasis and its application in preventing and treating bone diseases
    Ke Xu et al, 2023, Frontiers in Pharmacology CrossRef
21. The Role of SIRT3 in the Osteoporosis
    Siwang Hu et al, 2022, Frontiers in Endocrinology CrossRef
22. Purine metabolism in the development of osteoporosis
    Keda Yang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
23. Metformin prevents mandibular bone loss in a mouse model of accelerated aging by correcting dysregulated AMPK-mTOR signaling and osteoclast differentiation
    Boyang Liu et al, 2024, Journal of Orthopaedic Translation CrossRef